Feasibility Study of the JewelPump Version 3

Feasibility Study of the JewelPump Version 3

The study will be conducted, in cross-over with a time interval of at least 2 days between 2 treatment periods. Patients will be randomized into 2 groups According to the order of the randomization, patients will bear the JewelPump for 5 days, followed by a period of 5 days of treatment with their usual pumps.

The JewelPump (Debiotech) will be compared to the conventional pumps. Patients will treated with the JewelPump during 5 days, and with their usual pump during 5 other days.

The study will be conduct with 15 patients at the following investigation centers : Corbeil Hospital, CHU of Strasbourg, and CHRU of Marseille.

Inclusion Criteria:

• Patients type 1 diabetics treated by external insulin pump;
• Patients with HbA1c < 8.5%
• Patients who signed consent

Exclusion Criteria:

• Patients type 2 diabetics
• Patients who have all serious diseases that could interfere with the study